This review provides guidance on the medical and dental management of patients taking novel oral antithrombotics, highlighting bleeding risks and drug interactions.
Answers are grounded in this paper and cite their sources.
Supports cautious periprocedural decisions for dental patients on novel oral antithrombotics; leaves open the need for prospective validation of recommendations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Walters et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: